Biocidal properties of metal oxide nanoparticles and their halogen adducts

Nanoscale
Johanna A HaggstromGeorge L Marchin

Abstract

Nanosized metal oxide halogen adducts possess high surface reactivities due to their unique surface morphologies. These adducts have been used as reactive materials against vegetative cells, such as Escherichia coli as well as bacterial endospores, including Bacillus subtilis and Bacillus anthracis (Delta Sterne strain). Here we report high biocidal activities against gram-positive bacteria, gram-negative bacteria, and endospores. The procedure consists of a membrane method. Transmission electron micrographs are used to compare nanoparticle-treated and untreated cells and spores. It is proposed that the abrasive character of the particles, the oxidative power of the halogens/interhalogens, and the electrostatic attraction between the metal oxides and the biological material are responsible for high biocidal activities. While some activity was demonstrated, bacterial endospores were more resistant to nanoparticle treatment than the vegetative bacteria.

References

Feb 1, 1978·Journal of Clinical Pathology·D Coates, J E Death
Aug 1, 1975·Journal of General Microbiology·L R Wyatt, W M Waites
Dec 1, 1992·FEMS Microbiology Letters·N D Williams, A D Russell
Feb 1, 1992·The Journal of Applied Bacteriology·S F Bloomfield, M Arthur
Apr 1, 1990·Clinical Microbiology Reviews·A D Russell
Jul 1, 1985·The Journal of Applied Bacteriology·S P GormanE P Hutchinson
Dec 1, 1967·The Journal of Applied Bacteriology·M BrandrickJ A Vickers
Apr 1, 1967·The Journal of Applied Bacteriology·C M Cousins, C D Allan
Feb 1, 1983·The Journal of Applied Bacteriology·S P GormanL M McDermott
Apr 1, 1983·Applied and Environmental Microbiology·P M Foegeding, F F Busta
Apr 1, 1984·The Journal of Applied Bacteriology·S P GormanE P Hutchinson
May 1, 1994·The Journal of Applied Bacteriology·S F Bloomfield, R Megid
Jan 15, 1993·FEMS Microbiology Letters·N D Williams, A D Russell
Apr 3, 2001·Applied and Environmental Microbiology·C Barker, S F Park
Oct 16, 2003·Journal of the American Chemical Society·Peter K StoimenovKenneth J Klabunde

❮ Previous
Next ❯

Citations

May 15, 2012·Accounts of Chemical Research·Le HeYadong Yin
Jul 28, 2012·Environmental Science & Technology·Pranab DasMarguerite A Xenopoulos
Oct 5, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Le HeYadong Yin
Oct 28, 2011·Expert Review of Anti-infective Therapy·Adil M AllahverdiyevMiriam Rafailovich
Sep 2, 2014·Materials Science & Engineering. C, Materials for Biological Applications·María V RoldánNora S Pellegri
May 7, 2011·Journal of Hazardous Materials·Niraj KumarVirginia K Walker
Oct 25, 2011·Environmental Toxicology and Chemistry·Niraj KumarVirginia K Walker
Jun 21, 2017·Antimicrobial Resistance and Infection Control·Rafael Manuel Ortí-Lucas, Julio Muñoz-Miguel
Jun 12, 2019·International Journal of Molecular Sciences·Nereyda Niño-MartínezFacundo Ruiz
Oct 30, 2020·International Journal of Nanomedicine·Muhammad Usman MunirSajal Salman
Mar 17, 2021·Accounts of Chemical Research·Jonathan C Bennion, Adam J Matzger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.